Drug
Vir 5500
Vir 5500: highest development phase Phase 1, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| VIR-5500 NCT05997615 | Phase 1 | Hormone-refractory Prostate Cancer |
Latest
No recent events.
Follow Vir 5500 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.